Guardant Health
GH
$27.10
Share price
-1.35%
Change (1 day)
-13.67%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Guardant Health (GH) - Total debt
Total debt on the balance sheet as of March 2024 : $1.34 B
According to Guardant Health 's latest financial reports the company's total debt is $1.34 B. A company’s total debt is the sum of all current and non-current debts.
Guardant Health - Total debt on balance sheet (from 2017 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $1.35 B | -1.13% |
| 2022-12-31 | $1.36 B | -0.32% |
| 2021-12-31 | $1.37 B | 60.77% |
| 2020-12-31 | $0.85 B | 2015.28% |
| 2019-12-31 | $40.39 M | |
| 2018-12-31 | $N/A | -100% |
| 2017-12-31 | $0.65 M | -96.13% |
| 2016-12-31 | $17.03 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | $0.89 B | -33.94% | 🇺🇸 USA |
 Natera NTRA | $0.43 B | -67.36% | 🇺🇸 USA |